Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-Term Glycemic Response to DPP-4 Inhibitor Therapy.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620622
Title:
Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-Term Glycemic Response to DPP-4 Inhibitor Therapy.
Authors:
Dennis, J. M.; Shields, B.M.; Hill, A. V.; Knight, B. A.; McDonald, Timothy J. ( 0000-0003-3559-6660 ) ; Rodgers, L. R.; Weedon, M. N.; Henley, W. E.; Sattar, N.; Holman, R. R.; Pearson, E. R.; Hattersley, Andrew T.; Jones, A. G.
Abstract:
A precision approach to type 2 diabetes therapy would aim to target treatment according to patient characteristics. We examined if measures of insulin resistance and secretion were associated with glycemic response to dipeptidyl peptidase 4 (DPP-4) inhibitor therapy.
Citation:
Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-Term Glycemic Response to DPP-4 Inhibitor Therapy. 2018 Diabetes Care
Publisher:
American Diabetes Association
Journal:
Diabetes care
Issue Date:
31-Jan-2018
URI:
http://hdl.handle.net/11287/620622
DOI:
10.2337/dc17-1827
PubMed ID:
29386249
Additional Links:
http://care.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=29386249
Type:
Journal Article
Language:
en
ISSN:
1935-5548
Appears in Collections:
Diabetes/Endocrine Services; 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorDennis, J. M.en
dc.contributor.authorShields, B.M.en
dc.contributor.authorHill, A. V.en
dc.contributor.authorKnight, B. A.en
dc.contributor.authorMcDonald, Timothy J.en
dc.contributor.authorRodgers, L. R.en
dc.contributor.authorWeedon, M. N.en
dc.contributor.authorHenley, W. E.en
dc.contributor.authorSattar, N.en
dc.contributor.authorHolman, R. R.en
dc.contributor.authorPearson, E. R.en
dc.contributor.authorHattersley, Andrew T.en
dc.contributor.authorJones, A. G.en
dc.date.accessioned2018-03-02T14:55:46Z-
dc.date.available2018-03-02T14:55:46Z-
dc.date.issued2018-01-31-
dc.identifier.citationPrecision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-Term Glycemic Response to DPP-4 Inhibitor Therapy. 2018 Diabetes Careen
dc.identifier.issn1935-5548-
dc.identifier.pmid29386249-
dc.identifier.doi10.2337/dc17-1827-
dc.identifier.urihttp://hdl.handle.net/11287/620622-
dc.description.abstractA precision approach to type 2 diabetes therapy would aim to target treatment according to patient characteristics. We examined if measures of insulin resistance and secretion were associated with glycemic response to dipeptidyl peptidase 4 (DPP-4) inhibitor therapy.en
dc.language.isoenen
dc.publisherAmerican Diabetes Associationen
dc.relation.urlhttp://care.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=29386249en
dc.rightsArchived with thanks to Diabetes careen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.titlePrecision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-Term Glycemic Response to DPP-4 Inhibitor Therapy.en
dc.typeJournal Articleen
dc.identifier.journalDiabetes careen
dc.type.versionIn press (epub ahead of print)en
All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.